unani treatment for heal pain

Evaluation of the effect of Habbe Gul-e-Aakh and Rogan-e-Babuna in Waja-ul-Aqab (Heel Pain)- An Interventional study without control

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054152

Enrollment

Registered

2023-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M709- Unspecified soft tissue disorder related to use, overuse and pressure

Interventions

Intervention1: Habbe Gul-e-Aakh and Rogan-e-Babuna: Habbe Gul-e-Aakh(pills) which contains

1-Gul-e-Madar(Calotropis gigantean L) 2-Zanjabeel(Zingiber officinale Roscoe) 3-Filfil Siyah(Piper nigrum L) 4-Barg-e-Baans (Bambusa arundinacea Wild) dose

500mg twice daily for 15 days and Rogan-e-Babuna for local application 10ml twice daily for 15 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Pain in heel

Exclusion criteria

Exclusion criteria: 1. Subject of heel pain with Grade-1 and Grade-3 on VAS (Visual Analogue Scale). 2. Patients with the History of trauma and accidents involving Heel. 3. History of intraarticular steroid injection of Heel 4. Radiologically confirm cases of calcaneal spur 5. Patients with establish pathology over lower limb/ heel 6. Pregnant and Lactating Women

Design outcomes

Primary

Measure	Time frame
PFPS scale (Plantar Fasciitis Pain Scale)Timepoint: 15 days	—

Secondary

Measure	Time frame
VAS score(visual Analogue Scale)Timepoint: 15 days	—

Countries

India

Contacts

Public ContactProf Mohd Aleemuddin Quamri

NATIONAL INSTITUTE OF UNANI MEDICINE,

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026